Wageningen University received a subsidy of 12.5 million euros to create a vaccine against the mosquito borne virus Rift Valley Fever that is safe for humans. The subsidy comes from the Coalition for Epidemic Preparedness Innovation (CEPI), NOS reports.
Rift Valley Fever
